Unresected screen-detected ductal carcinoma in situ: Outcomes of 311 women in the Forget-Me-Not 2 study

被引:20
作者
Maxwell, Anthony J. [1 ,2 ]
Hilton, Bridget [3 ]
Clements, Karen [3 ]
Dodwell, David [4 ]
Dulson-Cox, Joanne [3 ]
Kearins, Olive [3 ]
Kirwan, Cliona [1 ,5 ]
Litherland, Janet [6 ]
Mylvaganam, Senthurun [7 ]
Provenzano, Elena [8 ]
Pinder, Sarah E. [9 ]
Sawyer, Elinor [10 ]
Shaaban, Abeer M. [11 ,12 ]
Sharma, Nisha [13 ]
Stobart, Hilary [14 ]
Wallis, Matthew G. [15 ,16 ]
Thompson, Alastair M. [17 ]
机构
[1] Manchester Univ NHS Fdn Trust, Wythenshawe Hosp, Nightingale Ctr, Southmoor Rd, Manchester M23 9LT, Lancs, England
[2] Univ Manchester, Fac Biol Med & Hlth, Sch Hlth Sci, Div Informat Imaging & Data Sci, Manchester M13 9PT, Lancs, England
[3] Publ Hlth England, 5 St Philips Pl, Birmingham B3 2PW, W Midlands, England
[4] Univ Oxford, Nuffield Dept Populat Hlth, Richard Doll Bldg,Old Rd Campus, Oxford OX3 7LF, England
[5] Univ Manchester, Fac Biol Med & Hlth, Div Canc Sci, Manchester M13 9PT, Lancs, England
[6] West Scotland Breast Screening Ctr, Nelson Mandela Pl, Glasgow G2 1QY, Lanark, Scotland
[7] Royal Wolverhampton NHS Trust, New Cross Hosp, Wolverhampton Rd, Wolverhampton WV10 0QP, England
[8] Addenbrookes Hosp, Dept Histopathol, Box 235,Hills Rd, Cambridge CB2 0QQ, England
[9] Kings Coll London, Guys Hosp, Div Canc Studies, St Thomas St, London SE1 9RT, England
[10] Kings Coll London, Guys Canc Ctr, Sch Canc & Pharmaceut Sci, London SE1 9RT, England
[11] Queen Elizabeth Hosp Birmingham, Birmingham B15 2GW, W Midlands, England
[12] Univ Birmingham, Birmingham B15 2GW, W Midlands, England
[13] Seacroft Hosp, Leeds Wakefield Breast Screening Serv, York Rd, Leeds LS14 6UH, W Yorkshire, England
[14] Independent Canc PatientsVoice, 17 Woodbridge St, London EC1R 0LL, England
[15] Cambridge Univ Hosp NHS Fdn Trust, Cambridge Breast Unit, Cambridge CB2 0QQ, England
[16] NIHR Cambridge Biomed Res Ctr, Cambridge CB2 0QQ, England
[17] Baylor Coll Med, Dan L Duncan Comprehens Canc Ctr, Houston, TX 77030 USA
关键词
Female; Breast; Breast neoplasms; Carcinoma; Intraductal; Nonin filtrating; Mass screening; Retrospective studies; Cohort studies; Registries; BREAST-CANCER; ACTIVE SURVEILLANCE; RISK; DCIS;
D O I
10.1016/j.breast.2022.01.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and aim: The natural history of ductal carcinoma in situ (DCIS) is poorly understood. The aim of this cohort study was to determine the outcomes of women who had no surgery for screen-detected DCIS in the 6 months following diagnosis. Methods: English breast screening databases were retrospectively searched for women diagnosed with DCIS without invasive cancer at screening and who had no record of surgery within 6 months of diagnosis. These were cross-referenced with cancer registry data. Details of the potentially eligible women were sent to the relevant breast screening units for verification and for completion of data forms detailing clinical, radiological and pathological findings, non-surgical treatment and subsequent clinical course. Results: Data for 311 eligible women (median age 62 years) were available. 60 women developed invasive cancer, 56 ipsilateral and 4 contralateral. Ipsilateral invasion risk increased approximately linearly with time for at least 10 years. The 10-year cumulative risk of ipsilateral invasion was 9% (95% CI 4 -21%), 39% (24-58%) and 36% (24-50%) for low, intermediate and high grade DCIS respectively and was higher in younger women, in those with larger DCIS lesions and in those with microinvasion. Most invasive cancers that developed were grade 2 or 3. Conclusion: The findings suggest that active surveillance may be a reasonable alternative to surgery in patients with low grade DCIS but that women with intermediate or high grade disease should continue to be offered surgery. This highlights the importance of reproducible grading of DCIS to ensure patients receive appropriate treatment. (c) 2022 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
引用
收藏
页码:145 / 155
页数:11
相关论文
共 27 条
  • [1] [Anonymous], BREAST SCREENING PRO, P20
  • [2] Ductal Carcinoma in Situ at Core-Needle Biopsy: Meta-Analysis of Underestimation and Predictors of Invasive Breast Cancer
    Brennan, Meagan E.
    Turner, Robin M.
    Ciatto, Stefano
    Marinovich, M. Luke
    French, James R.
    Macaskill, Petra
    Houssami, Nehmat
    [J]. RADIOLOGY, 2011, 260 (01) : 119 - 128
  • [3] The risk of a contralateral breast cancer among women diagnosed with ductal and lobular breast carcinoma in situ: data from the Connecticut Tumor Registry
    Claus, EB
    Stowe, M
    Carter, D
    Holford, T
    [J]. BREAST, 2003, 12 (06) : 451 - 456
  • [4] Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study
    Duffy, Stephen W.
    Dibden, Amanda
    Michalopoulos, Dimitrios
    Offman, Judith
    Parmar, Dharmishta
    Jenkins, Jacquie
    Collins, Beverley
    Robson, Tony
    Scorfield, Suzanne
    Green, Kathryn
    Hall, Clare
    Liao, Xiao-Hui
    Ryan, Michael
    Johnson, Fiona
    Stevens, Guy
    Kearins, Olive
    Sellars, Sarah
    Patnick, Julietta
    [J]. LANCET ONCOLOGY, 2016, 17 (01) : 109 - 114
  • [5] Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study
    Elshof, Lotte E.
    Tryfonidis, Konstantinos
    Slaets, Leen
    van Leeuwen-Stok, A. Elise
    Skinner, Victoria P.
    Dif, Nicolas
    Pijnappel, Ruud M.
    Bijker, Nina
    Rutgers, Emiel J. Th.
    Wesseling, Jelle
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 (12) : 1497 - 1510
  • [6] Overdiagnosis in breast imaging
    Evans, Andy
    Vinnicombe, Sarah
    [J]. BREAST, 2017, 31 : 270 - 273
  • [7] Addressing overtreatment of screen detected DCIS; the LORIS trial
    Francis, Adele
    Thomas, Jeremy
    Fallowfield, Lesley
    Wallis, Matthew
    Bartlett, John M. S.
    Brookes, Cassandra
    Roberts, Tracy
    Pirrie, Sarah
    Gaunt, Claire
    Young, Jennie
    Billingham, Lucinda
    Dodwell, David
    Hanby, Andrew
    Pinder, Sarah E.
    Evans, Andrew
    Reed, Malcolm
    Jenkins, Valerie
    Matthews, Lucy
    Wilcox, Maggie
    Fairbrother, Patricia
    Bowden, Sarah
    Rea, Daniel
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 (16) : 2296 - 2303
  • [8] Surgical Upstaging Rates for Vacuum Assisted Biopsy Proven DCIS: Implications for Active Surveillance Trials
    Grimm, Lars J.
    Ryser, Marc D.
    Partridge, Ann H.
    Thompson, Alastair M.
    Thomas, Jeremy S.
    Wesseling, Jelle
    Hwang, E. Shelley
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (12) : 3534 - 3540
  • [9] Ductal Carcinoma In Situ and Progression to Invasive Cancer: A Review of the Evidence
    Heller, Samantha L.
    Plaunova, Anastasia
    Gao, Yiming
    [J]. JOURNAL OF BREAST IMAGING, 2021, 3 (02) : 135 - 143
  • [10] The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS)
    Hwang, E. Shelley
    Hyslop, Terry
    Lynch, Thomas
    Frank, Elizabeth
    Pinto, Donna
    Basila, Desiree
    Collyar, Deborah
    Bennett, Antonia
    Kaplan, Celia
    Rosenberg, Shoshana
    Thompson, Alastair
    Weiss, Anna
    Partridge, Ann
    [J]. BMJ OPEN, 2019, 9 (03): : e026797